False
November 3, 2026
2 min read
The company also reported early efficacy and safety data from the Phase I Breakfree-2 study
November 3, 2026
23 min read
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation
November 3, 2026
3 min read
Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines
November 2, 2026
2 min read
Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited
False